Cardinal Health (NYSE:CAH) Releases FY 2025 Earnings Guidance

Cardinal Health (NYSE:CAH) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 7.900-7.900 for the period, compared to the consensus estimate of 8.720. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

CAH has been the subject of several analyst reports. Wells Fargo & Company raised shares of Cardinal Health from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $101.00 to $127.00 in a research note on Friday, December 13th. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $132.00 to $145.00 in a research note on Monday, January 6th. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price for the company in a research note on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft boosted their price target on Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Finally, StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $133.29.

Cardinal Health Trading Down 0.6 %

Shares of CAH opened at $126.27 on Friday. Cardinal Health has a 12 month low of $93.17 and a 12 month high of $127.27. The firm’s 50 day moving average is $120.75 and its 200-day moving average is $111.92. The stock has a market capitalization of $30.56 billion, a PE ratio of 24.57, a P/E/G ratio of 1.48 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $52.28 billion during the quarter, compared to analysts’ expectations of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.73 EPS. Equities research analysts predict that Cardinal Health will post 7.82 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were issued a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend was Thursday, January 2nd. Cardinal Health’s dividend payout ratio is currently 39.30%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.